US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine
As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Business, Spoken · SpokenLayer
July 8, 20246m 40s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025.
Learn about your ad choices: dovetail.prx.org/ad-choices